Of interest and article archive

Here you will find selected articles from our archive.
For historical articles, please see here.

Go back

February 28, 2024

Thor Medical ASA reports 2023 results – current focus on establishing pilot plant

February 21, 2024

Invitation to presentation of Thor Medical ASA's second half results 2023

February 14, 2024

Thor Medical employs Jasper Kurth as new CEO

December 22, 2023

Thor Medical ASA builds lab and pilot facilities at Herøya as key milestones towards industrial-scale production of alpha emitters

November 30, 2023

Thor Medical signs agreement to transfer its Nordic Nanovector patents to NucliThera

November 15, 2023

Thor Medical ASA signs LOI for offtake with US and Scandinavian based clinical trial stage companies

October 31, 2023

Thor Medical ASA expands expertise and positions for growth with two experienced chemistry professionals

August 31, 2023

Thor Medical ASA first half 2023 results

June 22, 2023

Nordic Nanovector announces agreement to acquire Thor Medical

June 18, 2023

Thor Medical is looking for an EHS Manager

Thor Medical logo

Contact
Thor Medical HQ

Karenslyst allé 9C
NO-0278 Oslo, Norway
Org.no: 994 297 422
MVA

+ 47 974 14 000

(08.00-16.00 CET)

post@thormedical.com

Design and development by

NXT Oslo Reklamebyrå

Sign up to news

Privacy statement

This service is operated by Investis Digital on behalf of Thor Medical. Investis Limited registered office is 24 Fashion Street, London, E1 6PX.

Full name
E-mail

Thank you!
Your submission has been received!

Oops! Something went wrong. Try again later.